AddLife shares are traded on Nasdaq Stockholm, Nordic Large Cap

ADD Lonsamhet Vit

The share

Chart Bar

Financial reports and presentations



Corporate governance

  • New President and CEO of AddLife

    We are excited to announce, that as of today, we have a new CEO, Fredrik Dalborg. Fredrik is succeeding Kristina Willgård, our former CEO of seven successful years since AddLife started.

    We welcome Fredrik and look forward to working with him!

    New CEO of AddLife
    Fredrik Dalborg AddLife

AddLife creates value

The laboratory and medical technology market is relatively insensitive to economic fluctuations. Growth tends to be stable and is mainly driven by population growth and an ageing population. These trends increase the demand for AddLife's healthcare and research products. Historically, the markets where we operate have grown at an annual rate of 2-4 percent.

AddLife’s subsidiaries are strongly cash generative, which gives financial opportunity for acquisitions and investments.

ADD Lonsamhet Vit

AddLife has substantial experience of acquisitions, identifying candidates and completing successful transactions.

ADD Ansvar Vit

AddLife’s subsidiaries have strong sales organisations with high technological expertise and long term customer relationships.

ADD Engagemang Vit

Target fulfilment 2021

Earnings growth



Contact us!

The investor pages contain all published financial information to facilitate investment decisions.

We are happy to assist you in understanding our business and financial results. Please do not hesitate to contact us if you would like more information, or if you have any suggestions for improving our service.

IR- and press contacts

Fredrik Dahlborg DSC 2592

Fredrik Dalborg


Christina Rubenhag (3)

Christina Rubenhag